In this study, we investigated the clinical efficacy and the effects on CT, CYFRA21-1 level, ProGRP level, and prognosis of 102 lung cancer patients treated with bevacizumab in combination with chemotherapy under preventive care intervention. This evidence concerns the gene GRP and lung cancer.